Finally, we show that the efficacy of DHE in suppressing SE-dependent expression of MYC in vitro, and MYC-dependent AML maintenance in vivo, is similar to that of BET bromodomain inhibitor JQ1. Here, DNER is linked to acute myeloid leukemia.